Markets
EBS

bluebird bio (BLUE) Zooms: Stock Up 7.2% - Tale of the Tape

bluebird bio, Inc. ( BLUE ) was a big mover last session, as its shares surged over 7% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the stock since Feb 5, as it is now up nearly 40%.

In the last 30 days, the company did not see any estimate revision and the Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

bluebird bio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the medical sector include Emergent BioSolutions, Inc. ( EBS ), Gilead Sciences Inc. ( GILD ) and Halozyme Therapeutics, Inc. ( HALO ). While Emergent and Gilead sport a Zacks Rank #1 (Strong Buy), Halozyme carries a Zacks Rank #2 (Buy) .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

BLUEBIRD BIO (BLUE): Free Stock Analysis Report

EMERGENT BIOSOL (EBS): Free Stock Analysis Report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

HALOZYME THERA (HALO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EBS GILD HALO BLUE

Other Topics

Investing Stocks